General Assembly Proposed Bill No. 5460
January Session, 2013 LCO No. 812
Referred to Committee on COMMERCE
Introduced by:
REP. RITTER E., 38th Dist. SEN. STILLMAN, 20th Dist. SEN. MAYNARD, 18th Dist. REP. JUTILA, 37th Dist. REP. URBAN, 43rd Dist. REP. HEWETT, 39th Dist. REP. WRIGHT E., 41st Dist. REP. RYAN, 139th Dist. REP. MOUKAWSHER, 40th Dist.
General Assembly
Proposed Bill No. 5460
January Session, 2013
LCO No. 812
Referred to Committee on COMMERCE
Introduced by:
REP. RITTER E., 38th Dist.
SEN. STILLMAN, 20th Dist.
SEN. MAYNARD, 18th Dist.
REP. JUTILA, 37th Dist.
REP. URBAN, 43rd Dist.
REP. HEWETT, 39th Dist.
REP. WRIGHT E., 41st Dist.
REP. RYAN, 139th Dist.
REP. MOUKAWSHER, 40th Dist.
AN ACT ESTABLISHING A MODEL PLAN FOR EMERGING BIOSCIENCE AND PHARMACEUTICAL BUSINESSES IN SOUTHEASTERN CONNECTICUT.
Be it enacted by the Senate and House of Representatives in General Assembly convened:
That title 32 of the general statutes be amended to require the Department of Economic and Community Development to develop a model plan to support bioscience and pharmaceutical start-up and emerging businesses in southeastern Connecticut that shall include, but not be limited to, quick response mechanisms, safeguards for appropriate use, targeted incentives, business formation support resources and strong integration with existing regional assets.
Statement of Purpose:
To facilitate the growth of a bioscience and pharmaceutical presence in southeastern Connecticut.